Article

Study Finds Chromoendoscopy Successfully Detects Dysplasia in Colitis Patients

Author(s):

Chromoendoscopy trumps random biopsy or white-light colonoscopy as a method for discovering dysplasia in inflammatory bowel diseases (IBD) patients.

Chromoendoscopy trumps random biopsy or white-light colonoscopy as a method for discovering dysplasia in inflammatory bowel diseases (IBD) patients.

While standard surveillance relies primarily on white light colonoscopy, non-targeted biopsies, targeted sampling, and lesion removal, the inexpensive stain feature in chromoendoscopy allows experts to highlight differences in mucosa indicating risk for colorectal cancer.

Research showed that chromoendoscopy was more likely to uncover precancerous lesions (dysplasia) when they were already present.

Furthermore, a negative chromoendoscopy result found that advanced dysplasia would not develop, thereby canceling any need for colon resections.

James F. Marion, MD, Professor of Medicine, Icahn School of Medicine at Mount Sinai, and Director of Education and Outreach at The Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center at The Mount Sinai Hospital, conducted a long-term surveillance study analyzing data from 68 Mount Sinai patients with ulcerative colitis (UC) or Crohn’s disease (CD).

The patients were followed from June 2006 through October 2011 and analyzed by random biopsy, targeted white-light examination, and chromoendoscopy. Among the 44 dysplastic lesions identified in 24 patients, 27 were by chromoendoscopy, 11 by white-light examination, and only 6 by random biopsy.

According to Marion, “Despite the abundant evidence supporting improved dysplasia detection in patients with IBD through chromoendoscopy screening and its incorporation into our guidelines, many gastroenterologists continue to reply on expensive random biopsies for detection of dysplasia and colorectal cancer. We hope these long-term findings resonate throughout the GI community and prompt screening changes, thus improving patient outcomes. Chromoendoscopy is an inexpensive, easy-to-learn technique that allows us to manage our patients without surgery. Our current guidelines will need to be revisited.”

Related Videos
Age, Race, Ethnicity Disparities Hinder Celiac Disease Screening, with Debra Silberg, MD, PhD
Lauren Collen, MD: Advanced Combination Therapy May Be Effective Option for Pediatric Refractory IBD
Lauren Collen, MD: Some Fragrances May be More Prevalent in Exposomes of Children with Crohn’s Disease
Impact of Long Hospital Stays on Pediatric Gastroparesis Management with Christian Sadaka, MD
Christian Sadaka, MD: Significant Increase in Pediatric Gastroparesis Hospital Admissions After COVID-19
Braden Kuo, MD | Credit: Mass Gen
Satish Rao, MD, PhD | Credit: ACG
Anthony Kerbage, MD | Credit: ResearchGate
© 2024 MJH Life Sciences

All rights reserved.